戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 xysteroid sulfotransferase (SULT2A1) binding dehydroepiandrosterone.
2 over 200 mg from cheap and readily available dehydroepiandrosterone.
3 = 0.34), androstenedione (+17.1%, P = 0.06), dehydroepiandrosterone (+14.4%, P = 0.02), and dehydroep
4 etic analogue of the chemopreventive hormone dehydroepiandrosterone, 16alpha-fluoro-5-androsten-17-on
5                                              Dehydroepiandrosterone (25 mg/kg/day) and/or prednisone
6 urated with its primary endogenous substrate dehydroepiandrosterone 3-sulfate (DHEA-S) to yield a 2.6
7 enyl S-glutathione, steroid sulfates such as dehydroepiandrosterone 3-sulfate (DHEAS) and estrone 3-s
8 ast to this finding, an active metabolite of dehydroepiandrosterone, 7-oxo-dehydroepiandrosterone, do
9 r arginine and/or glutamine, with or without dehydroepiandrosterone, a natural endogenous steroid, co
10 he 17-hydroxypregnenolone initial product to dehydroepiandrosterone, a process representing the first
11 lowing the adrenal to secrete high levels of dehydroepiandrosterone, an androgen precursor.
12 androgens with the additional measurement of dehydroepiandrosterone and 16-hydroxyprogesterone may al
13                                              Dehydroepiandrosterone and androstenediol (AED) have pre
14 onversion of the 17-hydroxylated steroids to dehydroepiandrosterone and androstenedione, respectively
15                  There was a suggestion that dehydroepiandrosterone and dehydroepiandrosterone sulfat
16 uantitative determination of hydroxysteroids dehydroepiandrosterone and pregnenolone and their main m
17 o 5alpha-dihydrotestosterone, which bypasses dehydroepiandrosterone and testosterone, with increased
18                     Steroidal (progesterone, dehydroepiandrosterone) and non-steroidal antagonists (v
19 progesterone, testosterone, androstenedione, dehydroepiandrosterone, and dehydroepiandrosterone sulfa
20 entrations of testosterone, androstenedione, dehydroepiandrosterone, and dehydroepiandrosterone sulfa
21 h using cyclosporine, mycophenolate mofetil, dehydroepiandrosterone, and intravenous immunoglobulin i
22 lucocorticoid antagonists, including RU-486, dehydroepiandrosterone, and progesterone.
23  anabolic-androgenic agents androstenedione, dehydroepiandrosterone, and the "parent" compound, testo
24  pregnenolone, progesterone, corticosterone, dehydroepiandrosterone, androstenedione, testosterone, 5
25 at/Km of the mutant is increased 6-fold with dehydroepiandrosterone as substrate.
26 termediate, yielding efficient production of dehydroepiandrosterone as the key intermediate in human
27 idoreductase deficiency results in disrupted dehydroepiandrosterone biosynthesis, explaining undervir
28 he prototypic hydroxysteroid SULT substrate, dehydroepiandrosterone, but both failed to catalyze the
29 eate the steroidogenic pathway upstream from dehydroepiandrosterone by documenting the presence of me
30          The pregnenolone, progesterone, and dehydroepiandrosterone content failed to change in rats
31                                      Whereas dehydroepiandrosterone conversion to DHT is usually very
32                                              Dehydroepiandrosterone (D) is biosynthesized in the brai
33 ernal standards, pregnenolone-d4 sulfate and dehydroepiandrosterone-d2 (DHEA), were used for quantita
34 one/testosterone), were significantly lower (dehydroepiandrosterone, Delta(4)-androstene-3,17-dione,
35                                              Dehydroepiandrosterone (DHEA) administration has been sh
36                               The effects of dehydroepiandrosterone (DHEA) and 7-oxo-DHEA on the cell
37 ubsequent 17alpha,20-lyase reactions to form dehydroepiandrosterone (DHEA) and androstenedione (Andro
38  progesterone to the C19 androgen precursors dehydroepiandrosterone (DHEA) and androstenedione, respe
39 y converted pregnenolone and progesterone to dehydroepiandrosterone (DHEA) and androstenedione, respe
40               In contrast, the production of dehydroepiandrosterone (DHEA) and DHEA sulfate in the ad
41 ex steroid synthesis from adrenal precursors dehydroepiandrosterone (DHEA) and DHEA-sulfate has evolv
42                          The adrenal steroid dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) ha
43                                              Dehydroepiandrosterone (DHEA) and its sulfate derivative
44                                              Dehydroepiandrosterone (DHEA) and its sulfate, DHEAS, ar
45 ymorphisms of the STS gene and SULT2A1 gene, dehydroepiandrosterone (DHEA) and its sulfated form (DHE
46 ions in hormone levels or precursors such as dehydroepiandrosterone (DHEA) and its sulfated form [col
47                                              Dehydroepiandrosterone (DHEA) and testosterone are widel
48  production of androgens, most significantly dehydroepiandrosterone (DHEA) and to a certain degree te
49 study was designed to assess the efficacy of dehydroepiandrosterone (DHEA) as a potential treatment.
50 oaded unimNPs with an endogenous S1R agonist dehydroepiandrosterone (DHEA) as an FDA-approved model d
51 s were conducted to evaluate the efficacy of dehydroepiandrosterone (DHEA) as an inhibitor of prostat
52 nd three women with INSR mutations underwent dehydroepiandrosterone (DHEA) challenge; serum androgens
53 S) concentrations by 88.2%, decreased plasma dehydroepiandrosterone (DHEA) concentrations by 84.6%, i
54              Age-related reductions in serum dehydroepiandrosterone (DHEA) concentrations may be invo
55 hypothesis that acute administration of oral dehydroepiandrosterone (DHEA) during episodes of repeate
56                          The adrenal steroid dehydroepiandrosterone (DHEA) has antiglucocorticoid pro
57                          The adrenal steroid dehydroepiandrosterone (DHEA) has been reported to act a
58                          The adrenal steroid dehydroepiandrosterone (DHEA) has no known cellular rece
59                      Pregnenolone (PREG) and dehydroepiandrosterone (DHEA) have been reported to impr
60 determine if the chemopreventive activity of dehydroepiandrosterone (DHEA) in the rat mammary gland c
61 ynthesis and release of the adrenal androgen dehydroepiandrosterone (DHEA) increases in response to s
62                                              Dehydroepiandrosterone (DHEA) is a C-19 adrenal steroid
63                                              Dehydroepiandrosterone (DHEA) is a neurosteroid with anx
64                                              Dehydroepiandrosterone (DHEA) is a neurosteroid with pot
65                                              Dehydroepiandrosterone (DHEA) is a peroxisome proliferat
66                  The adrenal steroid hormone dehydroepiandrosterone (DHEA) is a potent inhibitor of m
67                                              Dehydroepiandrosterone (DHEA) is a ubiquitous adrenal ho
68                                              Dehydroepiandrosterone (DHEA) is a weak androgen also us
69                                              Dehydroepiandrosterone (DHEA) is an endogenous adrenal s
70        The adrenal androgen and neurosteroid dehydroepiandrosterone (DHEA) is available as over-the-c
71 liferative effects of the endogenous steroid dehydroepiandrosterone (DHEA) is not known.
72                                              Dehydroepiandrosterone (DHEA) is the most abundant circu
73                                              Dehydroepiandrosterone (DHEA) is the most abundant stero
74 6, LPV/r-treated infants had a higher median dehydroepiandrosterone (DHEA) level than infants from th
75                    Imbalance of cortisol and dehydroepiandrosterone (DHEA) levels have been observed
76 kits were used to determine GCF cortisol and dehydroepiandrosterone (DHEA) levels.
77 t study examines the effect of administering dehydroepiandrosterone (DHEA) on short-term memory.
78               We have examined the effect of dehydroepiandrosterone (DHEA) on the development of EAE
79  This study examined the effect of exogenous dehydroepiandrosterone (DHEA) on the onset, incidence, a
80 article examines the effect of administering dehydroepiandrosterone (DHEA) on visual-spatial performa
81    Clinical studies showed that the androgen dehydroepiandrosterone (DHEA) reduced asthma symptoms in
82                                              Dehydroepiandrosterone (DHEA) regulates gene expression
83                              To determine if dehydroepiandrosterone (DHEA) replacement improves insul
84       One indicator of this interest is that dehydroepiandrosterone (DHEA) supplements are widely con
85                                 By contrast, dehydroepiandrosterone (DHEA) suppressed VZ cell prolife
86 1) catalyzes the rate-limiting conversion of dehydroepiandrosterone (DHEA) to androstenedione (AD), t
87 s an enzyme that catalyses the conversion of dehydroepiandrosterone (DHEA) to androstenedione, a crit
88 catalyzes peripheral conversion from adrenal dehydroepiandrosterone (DHEA) to potent androgens and ha
89                                              Dehydroepiandrosterone (DHEA), a 19-carbon precursor of
90                                              Dehydroepiandrosterone (DHEA), a C19 human adrenal stero
91          We apply this technology to release dehydroepiandrosterone (DHEA), a neurosteroid that promo
92  used in the prevention of osteoporosis, and dehydroepiandrosterone (DHEA), a ubiquitous steroid prec
93 to assess possible antidepressant effects of dehydroepiandrosterone (DHEA), an abundant adrenocortica
94 PA dysfunction, evident by altered cortisol, dehydroepiandrosterone (DHEA), and cortisol:DHEA levels.
95 , is correlated with early morning cortisol, dehydroepiandrosterone (DHEA), and/or dehydroepiandroste
96 between mice receiving either vehicle alone, dehydroepiandrosterone (DHEA), or 2-difluoromethylornith
97                            Administration of dehydroepiandrosterone (DHEA), or its sulfated form (DHE
98 nt with 5 mg/day testosterone (T), 75 mg/day dehydroepiandrosterone (DHEA), or placebo (P); and 57 el
99                                              Dehydroepiandrosterone (DHEA), the major steroid precurs
100                                              Dehydroepiandrosterone (DHEA), the predominant androgen
101  previous study showed that the neurosteroid dehydroepiandrosterone (DHEA), when administered preclin
102                      The adrenal sex hormone dehydroepiandrosterone (DHEA), which is present in serum
103 erator, nafenopin, with those of the steroid dehydroepiandrosterone (DHEA).
104 t ability to sulfate hydroxysteroids such as dehydroepiandrosterone (DHEA).
105 ls of total testosterone, free testosterone, dehydroepiandrosterone (DHEAS), androstenedione, luteini
106  metabolite of dehydroepiandrosterone, 7-oxo-dehydroepiandrosterone, does not activate AR target gene
107  was found for the inhibitory actions of the dehydroepiandrosterone enantiomers.
108 ion of androstenedione from progesterone and dehydroepiandrosterone from pregnenolone.
109  (epinephrine, norepinephrine, cortisol, and dehydroepiandrosterone), immune activity (C-reactive pro
110 st notably, we observed marked elevations in dehydroepiandrosterone in the axilla and androstenedione
111  and can further metabolize steroids such as dehydroepiandrosterone into potent androgens, the de nov
112                            The K(m) value of dehydroepiandrosterone is 13-fold greater, and the maxim
113                                              Dehydroepiandrosterone is the most abundant adrenal andr
114 -called 'anti-aging molecules', for example, dehydroepiandrosterone, is linked with enhanced lifespan
115  Further evidence was presented showing that dehydroepiandrosterone, leflunomide, and methotrexate ar
116 tive protein and lower free testosterone and dehydroepiandrosterone levels.
117    Low-dose vaginal estrogen, lidocaine, and dehydroepiandrosterone may also be considered in some ca
118       Both arginine and glutamine as well as dehydroepiandrosterone may be useful therapeutic agents
119 rost-1,5-diene-17-ethylene ketal (ADEK) from dehydroepiandrosterone metabolites and derivatives as a
120 mary metabolic route for the modification of dehydroepiandrosterone neurosteroids in the brain.
121  of those pathways and a specific inhibitor (dehydroepiandrosterone) of glucose-6-phosphate dehydroge
122            In rats, pretreatment with either dehydroepiandrosterone or fluvoxamine, a high-affinity s
123  reactions on a single protein that converts dehydroepiandrosterone or pregnenolone to androstenedion
124 phate dehydrogenase (G6PD) by treatment with dehydroepiandrosterone or the antisense DNA oligomer of
125 ng G6PD activity using an inhibitor of G6PD (dehydroepiandrosterone) or by inhibiting G6PD expression
126 hydroxyindoleacetic acid, homovanillic acid, dehydroepiandrosterone, or pregnenolone.
127 11-ketotestosterone, had significantly lower dehydroepiandrosterone (p < 0.001).
128         In the formation of the male hormone dehydroepiandrosterone, pregnenolone is first hydroxylat
129                    We previously showed that dehydroepiandrosterone protects against renal ischemia-r
130 infected PLSJL mice with the steroid hormone dehydroepiandrosterone reduced BBB permeability changes
131                                              Dehydroepiandrosterone-replacement therapy has been intr
132 rone and pregnenolone to androstenedione and dehydroepiandrosterone, respectively, via 17alpha-hydrox
133 d arginine plus glutamine and treatment with dehydroepiandrosterone reversed the susceptibility to in
134 eutical treatments include the mild androgen dehydroepiandrosterone, selective estrogen receptor modu
135 otransferase (EST), and a hydroxysteroid ST, dehydroepiandrosterone ST (DHEA-ST).
136 ancer cell lines showed only trace levels of dehydroepiandrosterone ST and hEST activities.
137 onoamine-sulfating forms of phenol ST (PST), dehydroepiandrosterone ST, and estrogen ST (hEST), were
138                  We previously reported that dehydroepiandrosterone-stimulated phosphorylation of Fox
139 hydroepiandrosterone (+14.4%, P = 0.02), and dehydroepiandrosterone sulfate (+7.2%, P = 0.26) compare
140                 The unnatural enantiomers of dehydroepiandrosterone sulfate (1), pregnenolone sulfate
141  in saliva and found significantly increased dehydroepiandrosterone sulfate (DHEA-S) and reduced estr
142                          The adrenal steroid dehydroepiandrosterone sulfate (DHEA-S) has been shown i
143  body of research has provided evidence that dehydroepiandrosterone sulfate (DHEA-S) is involved in a
144 monstrate the utility of the nanosensor with dehydroepiandrosterone sulfate (DHEA-S), a small-molecul
145 easing hormone, adrenocorticotropic hormone, dehydroepiandrosterone sulfate (DHEA-S), and cortisol.
146 ing retinoic acid and the endogenous steroid dehydroepiandrosterone sulfate (DHEA-S), it also has a c
147 port that chronic exposure to high levels of dehydroepiandrosterone sulfate (DHEA-S; converted in viv
148                                The effect of dehydroepiandrosterone sulfate (DHEAS) administered i.p.
149 tmenopausal serum levels of testosterone and dehydroepiandrosterone sulfate (DHEAS) and subsequent ri
150 ements of serum cortisol, corticotropin, and dehydroepiandrosterone sulfate (DHEAS) are used to diagn
151 adult male mice with the neuroactive steroid dehydroepiandrosterone sulfate (DHEAS) at 1 and 40 mg/kg
152  associations between obesity indicators and dehydroepiandrosterone sulfate (DHEAS) at 7 y of age and
153 (DU-14) to rats for 15 days increased plasma dehydroepiandrosterone sulfate (DHEAS) concentrations by
154 could identify hits that sense steroids like dehydroepiandrosterone sulfate (DHEAS) down to 1.3 uM wi
155                         Here, we report that dehydroepiandrosterone sulfate (DHEAS) is an endogenous
156 th PCOS have insulin resistance and elevated dehydroepiandrosterone sulfate (DHEAS) levels, which sup
157  (r > -0.6), bioavailable testosterone (BT), dehydroepiandrosterone sulfate (DHEAS), and the ratio of
158 ed inversely with plasma androstenedione and dehydroepiandrosterone sulfate (DHEAS), averaged across
159 terone, sex hormone-binding globulin (SHBG), dehydroepiandrosterone sulfate (DHEAS), luteinizing horm
160  neurosteroids such as pregnenolone sulfate, dehydroepiandrosterone sulfate (DHEAS), pregnanolone, an
161 characterized by the usual overproduction of dehydroepiandrosterone sulfate (DHEAS), whose detection
162 nasteride revealed a significant increase in dehydroepiandrosterone sulfate (DHEAS).
163 fated steroids pregnenolone sulfate (PS) and dehydroepiandrosterone sulfate (DHEAS).
164 A receptor by another sulfated neurosteroid, dehydroepiandrosterone sulfate (DHEAS).
165 sterone, free testosterone, androstenedione, dehydroepiandrosterone sulfate (DHEAS)], sex hormone bin
166 ine in serum testosterone, androsterone, and dehydroepiandrosterone sulfate (P < .05 for all).
167 inding protein B [S100B]), stress (cortisol, dehydroepiandrosterone sulfate [DHEA-S] epinephrine, nor
168  that endogenous sex hormones (testosterone, dehydroepiandrosterone sulfate [DHEA-S], and estradiol)
169 inhibitory steroids pregnenolone sulfate and dehydroepiandrosterone sulfate act through a common inte
170 PREGS potentiation of mEPSCs was mimicked by dehydroepiandrosterone sulfate and (+)-pentazocine but n
171 ibition of OATP1B3-1B7-mediated transport of dehydroepiandrosterone sulfate and identified several in
172 ational study found lower, but still normal, dehydroepiandrosterone sulfate concentrations in statin-
173        The levels of the AR ligand precursor dehydroepiandrosterone sulfate correlated positively wit
174                                              Dehydroepiandrosterone sulfate had a borderline associat
175     We examined testosterone, estradiol, and dehydroepiandrosterone sulfate in relation to incident A
176 served enantioselectivity for the actions of dehydroepiandrosterone sulfate indicates that its inhibi
177 , via administration of the enzyme substrate dehydroepiandrosterone sulfate or the enzyme inhibitor C
178 androstenedione, dehydroepiandrosterone, and dehydroepiandrosterone sulfate were associated with risk
179 androstenedione, dehydroepiandrosterone, and dehydroepiandrosterone sulfate were determined by liquid
180 a suggestion that dehydroepiandrosterone and dehydroepiandrosterone sulfate were inversely associated
181 androgens testosterone, androstenedione, and dehydroepiandrosterone sulfate were negatively associate
182 impact of SLCO2B1 expression level on DHEAS (dehydroepiandrosterone sulfate) uptake was evaluated in
183  baseline SA (testosterone, androstenedione, dehydroepiandrosterone sulfate), was measured by ultrase
184 ports taurocholic acid, the adrenal androgen dehydroepiandrosterone sulfate, and thyroid hormone, as
185  physical activity, social class, education, dehydroepiandrosterone sulfate, androstanediol glucuroni
186 terol, high-density lipoprotein cholesterol, dehydroepiandrosterone sulfate, cortisol, systolic and d
187 rone sulfate, androstenedione, testosterone, dehydroepiandrosterone sulfate, follicle-stimulating hor
188 s of estrone, estradiol, testosterone, SHBG, dehydroepiandrosterone sulfate, free estradiol, and free
189 +CD38+HLA-DR+, and CD8+CD38+HLA-DR+ T cells, dehydroepiandrosterone sulfate, free testosterone, homeo
190 re found for endogenous estrogens, cortisol, dehydroepiandrosterone sulfate, insulin, glucagon, or fo
191 lerosis and increasing quartiles of estrone, dehydroepiandrosterone sulfate, or androstenedione.
192 a,17beta-diol disulfate 2, P = 0.000064; and dehydroepiandrosterone sulfate, P = 0.00011).
193 iol, estrone, estrone sulfate, testosterone, dehydroepiandrosterone sulfate, prolactin, and sex hormo
194 tic levels of testosterone, androstenedione, dehydroepiandrosterone sulfate, sex hormone-binding glob
195 ten-3beta,17beta-diol disulfate 1 and 2, and dehydroepiandrosterone sulfate, were the next most stron
196 on of ERK1 and ERK2; however, the steroid PP dehydroepiandrosterone sulfate, which does not induce im
197 , but not by phenobarbital or the steroid PP dehydroepiandrosterone sulfate.
198 allo-tetrahydrocortisol, and the presence of dehydroepiandrosterone sulfate.
199 licle-stimulating hormone, testosterone, and dehydroepiandrosterone sulfate.
200 itor oxythiamine (OT) and the G6PD inhibitor dehydroepiandrosterone-sulfate (0.5 microM each) exerted
201 iveness and lower levels of androstenedione, dehydroepiandrosterone-sulfate (DHEA-S) and free PSA%, a
202 tisol, dehydroepiandrosterone (DHEA), and/or dehydroepiandrosterone-sulfate (DHEA-S) concentrations.
203 1.16-3.57; P = 0.01), lower plasma levels of dehydroepiandrosterone-sulfate (OR per 1-ln decrease = 2
204 1.16-3.57; P = 0.01), lower plasma levels of dehydroepiandrosterone-sulfate (OR per 1-ln decrease = 2
205 udy to determine whether hormone levels (E2, dehydroepiandrosterone-sulfate [DHEA-S], and testosteron
206           In vivo testing of 400 mg/kg OT or dehydroepiandrosterone-sulfate in C57BL/6 mice hosting E
207                                              Dehydroepiandrosterone-sulfate, a unique PP in being a s
208 activation via sulfonation of the hormone by dehydroepiandrosterone sulfotransferase (DST), an androg
209                                              Dehydroepiandrosterone sulfotransferase (Std) catalyzes
210                                              Dehydroepiandrosterone sulfotransferase (STD) is a hydro
211 xpression of the phase II conjugating enzyme dehydroepiandrosterone sulfotransferase (STD) known to s
212                                              Dehydroepiandrosterone sulfotransferase (SULT2A1) is a c
213 phenol sulfotransferases, HAST1, -3, and -4, dehydroepiandrosterone sulfotransferase, and estrogen su
214 nfluence steroid/xenobiotic metabolism using dehydroepiandrosterone sulfotransferase.
215 bum lipids and the immunostimulatory hormone dehydroepiandrosterone sulphate in the COVID-19 positive
216 depression scores; higher baseline cortisol: dehydroepiandrosterone sulphate ratio (men only) and hig
217           Evidence is accruing in support of dehydroepiandrosterone supplementation in adrenal insuff
218 o-conjugation of endogenous hydroxysteroids (dehydroepiandrosterone, testosterone, bile acids), and d
219 ollowed by a 17,20-lyase reaction to produce dehydroepiandrosterone, the key intermediate in human sy
220 erone and dihydrotestosterone, together with dehydroepiandrosterone, the precusrsor to all androgens,
221 n the other hand, neither isoform sulfonates dehydroepiandrosterone to any significant degree.
222 in conversion of the adrenal-derived steroid dehydroepiandrosterone to DHT.
223  and oxidizes cholesterol, pregnenolone, and dehydroepiandrosterone to their respective 3-keto-4-ene
224 The enzyme shows no substrate preference for dehydroepiandrosterone versus pregnenolone with second-o
225                              The presence of dehydroepiandrosterone was associated with 16-hydroxypro
226                                    Preflight dehydroepiandrosterone was positively associated with co
227                                              Dehydroepiandrosterone was reduced in the cachectic pati
228          Among 22 derivatives/metabolites of dehydroepiandrosterone, we found 4 steroids [no. 4, 1,3,
229 limits of androsterone, epiandrosterone, and dehydroepiandrosterone were 1-2 orders of magnitude grea
230 ficient subjects, plasma androstenedione and dehydroepiandrosterone were in a range similar to that o
231 f both 1 alpha, 25-dihydroxy vitamin D 3 and dehydroepiandrosterone were used together as hormonal im
232 regnanolone, pregnenolone, testosterone, and dehydroepiandrosterone) were isolated from the plasma or
233 ds through the adrenal sex steroid precursor dehydroepiandrosterone, which is converted to testostero
234  of men were identified with low circulating dehydroepiandrosterone who showed altered adrenal steroi
235     Trilostane is a competitive inhibitor of dehydroepiandrosterone with a Ki of 197 +/- 8 microM.

 
Page Top